| Not Yet Recruiting | Peripheral Helper T-cells in Common Variable ImmunoDeficiency NCT07255157 | University Hospital, Bordeaux | N/A |
| Recruiting | Usage of Spirometry in Managing IgG Therapy in CVID with Airway Disease NCT05193552 | University of Alabama at Birmingham | Phase 4 |
| Recruiting | Prediction of Portal Hypertension in Patients With CVID (CVID-pHT) NCT06145100 | University Hospital Freiburg | — |
| Enrolling By Invitation | Senolytics Treatment of Interstitial Lung Disease in Common Variable Immunodeficiency NCT05593588 | Avni Joshi | Phase 2 |
| Completed | Bronchiectasis Prevalence in Patients With Primary Humoral Immunodefiency in Champagne-Ardenne Region, France NCT06355323 | CHU de Reims | N/A |
| Unknown | Composition and Function of Gut Microbiota in Porto-sinusoidal Vascular Disease Associated With Variable Commo NCT05481554 | Assistance Publique - Hôpitaux de Paris | — |
| Active Not Recruiting | COVID-19 Vaccine Responses in PIDD Subjects NCT05321407 | Duke University | — |
| Recruiting | Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease NCT04925375 | Children's Hospital Medical Center, Cincinnati | Phase 2 |
| Recruiting | Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity NCT04339777 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Lymphocyte Immunophenotyping in Common Variable Immunodeficiency NCT01196702 | Barts & The London NHS Trust | — |
| Active Not Recruiting | Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation NCT03663933 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation NCT03513328 | University of Florida | Phase 1 / Phase 2 |
| Completed | The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Di NCT03211689 | Stockton University | N/A |
| Completed | Breadth of Donor Options for People With Inherited Diseases Requiring Allogeneic Hematopoietic Stem Cell Trans NCT03188419 | National Cancer Institute (NCI) | — |
| Recruiting | Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies NCT02579967 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases NCT01884311 | Bio Products Laboratory | Phase 3 |
| Completed | Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex NCT01963143 | Bio Products Laboratory | Phase 3 |
| Active Not Recruiting | Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies NCT01652092 | Masonic Cancer Center, University of Minnesota | N/A |
| Completed | A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency NCT01289847 | Bio Products Laboratory | Phase 4 |
| Completed | Human IgGs and Endothelial Function in Vivo in Humans NCT03534479 | Federico II University | N/A |
| Recruiting | Natural History of Bronchiectasis NCT00943514 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Terminated | "Prime Boost" Vaccination Strategy Combining Conjugated Anti- Pneumococcal Vaccine (s0) and Polysaccharide Ant NCT01489618 | Institut National de la Santé Et de la Recherche Médicale, France | Phase 2 |
| Completed | Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy NCT00542997 | CSL Behring | Phase 3 |
| Completed | Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency NCT00520494 | CSL Behring | Phase 4 |
| Completed | STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable Immunodeficiency NCT00263237 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID) NCT00322556 | CSL Behring | Phase 3 |
| Completed | Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID) NCT00168012 | CSL Behring | Phase 3 |
| Completed | Efficacy and Safety of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID) NCT00168025 | CSL Behring | Phase 3 |
| Completed | Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients NCT00220766 | Grifols Therapeutics LLC | Phase 3 |
| Completed | Specific IgG Antibody in Patients With Primary Antibody Deficiencies Treated With Subcutaneous Immunoglobulin NCT00661401 | Federal University of São Paulo | N/A |
| Completed | Immune System and Gut Abnormalities in Patients With Common Variable Immunodeficiency With and Without Gastroi NCT00015431 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Terminated | Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies NCT00006054 | Fairview University Medical Center | N/A |
| Completed | Randomized Study of Polyethylene-Glycol-Conjugated Interleukin 2 in Patients With Common Variable Immunodefici NCT00004695 | Icahn School of Medicine at Mount Sinai | N/A |